 | CANCER PREVENTION: MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS
Copyright © 2001 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 952:36-43 (2001)
© 2001 New York Academy of Sciences
Hormonal Prevention of Hereditary Breast Cancer
STEVEN A. NAROD
The Centre for Research on Women's Health, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada M5G 1N8
Address for correspondence: Dr. Steven Narod, Centre for Research on Women's Health, Women's College Hospital, 790 Bay Street, Room 750a, Toronto, Ontario, Canada M5G IN8. Voice: 416-351-3675; fax: 416-351-3767.
steven.narod{at}swchsc.on.ca
Women who carry a mutation in the BRCA1 or BRCA2 genes face a lifetime risk of developing breast cancer that approaches 80%. Among women with predisposing BRCA mutations, the risk of breast cancer is influenced by environmental factors and by modifying genes. Through the study of cohorts of female BRCA1 and BRCA2 carriers, several modifying factors have been identified. The risk of breast cancer is increased by early parity and is decreased by breast feeding, by oophorectomy, and by cigarette smoking. Many of the stragegies for breast cancer prevention involve estrogen deprivation and it is important to consider the acute and long-term effects of induced menopause in young women at high risk for breast cancer. There are no data so far on whether hormonal replacement therapy is hazardous in carriers of BRCA mutations.
Key Words: hereditary breast cancer • BRCA1, BRCA2 gene • hormonal prevention
This article has been cited by other articles:
|
|
|
|
 
J. B Greer and D. C Whitcomb
Role of BRCA1 and BRCA2 mutations in pancreatic cancer
Gut,
May 1, 2007;
56(5):
601 - 605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ma, P. Katiyar, L. P. Jones, S. Fan, Y. Zhang, P. A. Furth, and E. M. Rosen
The Breast Cancer Susceptibility Gene BRCA1 Regulates Progesterone Receptor Signaling in Mammary Epithelial Cells
Mol. Endocrinol.,
January 1, 2006;
20(1):
14 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, S. Fan, Q. Meng, Y. Ma, P. Katiyar, R. Schlegel, and E. M. Rosen
BRCA1 Interaction with Human Papillomavirus Oncoproteins
J. Biol. Chem.,
September 30, 2005;
280(39):
33165 - 33177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E M Rosen, S Fan, and C Isaacs
BRCA1 in hormonal carcinogenesis: basic and clinical research
Endocr. Relat. Cancer,
September 1, 2005;
12(3):
533 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wang, S. Fan, Z. Li, M. Fu, M. Rao, Y. Ma, M. P. Lisanti, C. Albanese, B. S. Katzenellenbogen, P. J. Kushner, et al.
Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor {alpha} Activity
Cancer Res.,
August 1, 2005;
65(15):
6557 - 6567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Schover
Motivation for Parenthood After Cancer: A Review
J Natl Cancer Inst Monographs,
March 1, 2005;
2005(34):
2 - 5.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. C. Friedman and R. M. Kramer
Reproductive Issues for Women With BRCA Mutations
J Natl Cancer Inst Monographs,
March 1, 2005;
2005(34):
83 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Pal, J. Permuth-Wey, T. Holtje, and R. Sutphen
BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2004;
13(11):
1794 - 1799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Medina and F. S. Kittrell
p53 Function Is Required for Hormone-Mediated Protection of Mouse Mammary Tumorigenesis
Cancer Res.,
October 1, 2003;
63(19):
6140 - 6143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Hoogerbrugge, P. Bult, L.M. de Widt-Levert, L.V. Beex, L.A. Kiemeney, M.J.L. Ligtenberg, L.F. Massuger, C. Boetes, P. Manders, and H.G. Brunner
High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer
J. Clin. Oncol.,
January 1, 2003;
21(1):
41 - 45.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
